MENLO PARK, Calif.--(BUSINESS WIRE)--Intersect ENT, Inc. (NASDAQ: XENT), a company seeking to improve the quality of life for patients with ear, nose and throat conditions, today announced that it ...

MENLO PARK, Calif.--(BUSINESS WIRE)--Intersect ENT, Inc. (NASDAQ: XENT), a company dedicated to transforming care for patients with ear, nose and throat conditions, today announced that it will ...

Intersect ENT expects to grow its revenue in 2021 compared to 2019, according to its preliminary fourth-quarter revenue report for last year. 1. Preliminary and unaudited revenue for the fourth ...